| Dec'17 | ||||||
|---|---|---|---|---|---|---|
Research and development expenses | ||||||
3,318 | ||||||
General and administrative expenses | ||||||
3,729 | ||||||
Other Income | ||||||
0 | ||||||
Total operating expenses | ||||||
7,047 | ||||||
Operating loss | ||||||
-7,047 | ||||||
Financial income | ||||||
29 | ||||||
Financial expenses | ||||||
1,123 | ||||||
Total comprehensive loss | ||||||
-8,141 | ||||||
Loss per share: | ||||||
Basic and diluted loss per share | ||||||
0.07 | ||||||
Basic and diluted loss per ADS | ||||||
1.46 | ||||||
Weighted average number of shares outstanding used to compute basic and diluted loss per share | ||||||
111,968 | ||||||